![Pledpharma ab](/api/images/company-pic/default.png)
Свяжитесь с нами
О компании
PledPharma AB, a pharmaceutical company, develops various pharmaceutical products to treat life threatening diseases. It primarily develops PledOx that is in Phase IIb clinical trials to reduce severe side effects of chemotherapy in patients with colorectal cancer. The company’s project pipeline includes Aladote (PP-100), which is in the Phase II clinical trials for the treatment of acute liver failure in conjunction with acetaminophen poisoning; and PP-099 that has completed Phase IIa clinical trials for the treatment of acute myocardial infarction.
SE
Неизвестно
Не проверенная компания
Прозрачность бизнеса
- Не проверена информация о компании
- Спрашивает отзывы у своих клиентов
- Не ответил на негативные отзывы